Intraoperative Use of Dexketoprofen Trometamol, Pethidine Hcl, Tramadol Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication

Sponsor
Kavaklıdere Umut Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01558622
Collaborator
(none)
72
1
6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the analgesic effects of dexketoprofen trometamol, tramadol hydrochloride, pethidine hydrochloride and their combinations in laparoscopic Nissen fundoplication.

Condition or Disease Intervention/Treatment Phase
  • Drug: dexketoprofen trometamol
  • Drug: tramadol hydrochloride
  • Drug: pethidine hydrochloride
  • Drug: dexketoprofen trometamol + tramadol hydrochloride
  • Drug: dexketoprofen trometamol + pethidine hydrochloride
  • Drug: vitamin c
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Intraoperative Use of Dexketoprofen Trometamol, Tramadol Hcl, Pethidine Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication
Study Start Date :
Mar 1, 2012
Anticipated Primary Completion Date :
May 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: dexketoprofen trometamol

Dexketoprofen trometamol is a water-soluble salt of the dextrorotatory enantiomer of the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen.

Drug: dexketoprofen trometamol
50mg intravenous infusion

Placebo Comparator: tramadol hydrochloride

Tramadol Hydrochloride is a well-known centrally acting opioid pain killer.

Drug: tramadol hydrochloride
100mg intravenous infusion

Placebo Comparator: pethidine hydrochloride

Pethidine is a synthetic opioid analgesic which produces a pattern of effects similar to morphine the standard against which opioid analgesics are compared.

Drug: pethidine hydrochloride
50mg intravenous infusion

Placebo Comparator: dexketoprofen trometamol + tramadol hydrochloride

Drug: dexketoprofen trometamol + tramadol hydrochloride
intravenous infusion of 50mg dexketoprofen trometamol + 100mg tramadol hydrochloride

Placebo Comparator: dexketoprofen trometamol + pethidine hydrochloride

Drug: dexketoprofen trometamol + pethidine hydrochloride
intravenous infusion of 50mg dexketoprofen trometamol + 50mg pethidine hydrochloride

Placebo Comparator: vitamin c

Drug: vitamin c
500mg intravenous infusion

Outcome Measures

Primary Outcome Measures

  1. Allergic reactions to NSAIDs or opioid analgesics, body mass index exceeding 35 [postoperative 2 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-60 years old ASA I-II patients

  • Clinical diagnosis of gastroesophageal reflux patients

Exclusion Criteria:
  • Allergic reactions to NSAIDs or opioid analgesics

  • Body mass index exceeding 35

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kavaklidere Umut Hospital Ankara Turkey 06660

Sponsors and Collaborators

  • Kavaklıdere Umut Hospital

Investigators

  • Principal Investigator: GOKHAN GOKMEN, Specialist,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GOKHAN GOKMEN, Anesthesiologist, MD, Kavaklıdere Umut Hospital
ClinicalTrials.gov Identifier:
NCT01558622
Other Study ID Numbers:
  • KVDU 0001 GG
First Posted:
Mar 20, 2012
Last Update Posted:
Mar 23, 2012
Last Verified:
Mar 1, 2012

Study Results

No Results Posted as of Mar 23, 2012